The DOI matches its Crossref record; 263 of the 263 references it cites were found in a registry or an index.
Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics
Open accessAbstract
BACKGROUND: Uterine leiomyoma (also known as fibroid or myoma) is the most common benign tumor of the uterus found in women of reproductive age. It is not usually fatal but can produce serious clinical symptoms, including excessive uterine bleeding, pelvic pain or pressure, infertility and pregnancy complications. Due to lack of effective medical treatments surgery has been a definitive choice for the management of this tumor. OBJECTIVE AND RATIONALE: Extracellular matrix (ECM) accumulation and remodeling are thought to be crucial for fibrotic diseases such as uterine leiomyoma. Indeed, ECM plays important role in forming the bulk structure of leiomyoma, and the ECM-rich rigid structure within these tumors is thought to be a cause of abnormal bleeding and pelvic pain. Therefore, a better understanding of ECM accumulation and remodeling is critical for developing new therapeutics for uterine leiomyoma. SEARCH METHODS: PubMed and Google Scholar were searched for all original and review articles/book chapters related to ECM and medical treatments of uterine leiomyoma published in English until May 2017. OUTCOMES: This review discusses the involvement of ECM in leiomyoma pathogenesis as well as current and future medical treatments that target ECM directly or indirectly. Uterine leiomyoma is characterized by elevated levels of collagens, fibronectin, laminins and proteoglycans. They can induce the mechanotransduction process, such as activation of the integrin-Rho/p38 MAPK/ERK pathway, resulting in cellular responses that are involved in pathogenesis and altered bidirectional signaling between leiomyoma cells and the ECM. ECM accumulation is affected by growth factors (TGF-β, activin-A and PDGF), cytokines (TNF-α), steroid hormones (estrogen and progesterone) and microRNAs (miR-29 family, miR-200c and miR-93/106b). Among these, TGF-βs (1 and 3) and activin-A have been suggested as key players in the accumulation of excessive ECM (fibrosis) in leiomyoma. The presence of elevated levels of ECM and myofibroblasts in leiomyoma supports the fibrotic character of these tumors. Interestingly, ECM may serve as a reservoir of profibrotic growth factors and enhance their activity by increasing their stability and extending their duration of signaling. At present, several classes of compounds, including gonadotropin-releasing hormone (GnRH) agonist (leuprolide acetate), GnRH antagonist (cetrorelix acetate), selective progesterone receptor modulators (ulipristate acetate and asoprisnil), antiprogestin (mifepristone) and natural compounds like vitamin D and resveratrol have been studied as medical treatments that target ECM in uterine leiomyoma. WIDER IMPLICATIONS: Although several types of drugs (mostly antiproliferative agents) are available for leiomyoma treatment, none of them were introduced specifically as antifibrotic agents. In light of its critical role in the process of fibrosis in leiomyoma, we propose that ECM should be considered as a crucial target for future therapeutics. Thus, the introduction of drugs that are specifically antifibrotic could be a good solution to control abnormal leiomyoma growth and associated clinical symptoms. The antifibrotic compounds can be introduced based on their ability to regulate ECM components and their receptors, as well as growth factors, cytokines, steroid hormones and their corresponding receptors and intracellular signaling pathways, as well as microRNAs, involved in ECM production in leiomyoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–263 of 263
Moore, A. B., Yu, L. C., Swartz, C. D., Zheng, X., Wang, L., Castro, L., Kissling, G. E., Walmer, D. K., Robboy, S. J., & Dixon, D. (2010) · Cell Communication and Signaling · doi:10.1186/1478-811x-8-10 · Cited by 61
All-trans retinoic acid: tolerance and biologic effects in myelodysplastic syndrome.
Kurzrock, R., Estey, E. H., & Talpaz, M. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.8.1489 · Cited by 61
Morikawa, A., Ohara, N., Xu, Q., Nakabayashi, K., DeManno, D. A., Chwalisż, K., Yoshida, S., & Maruo, T. (2008) · Human Reproduction · doi:10.1093/humrep/den025 · Cited by 60
Levens, E., Luo, X., Ding, L. J., et al. (2005) · Molecular Human Reproduction · doi:10.1093/molehr/gah187 · Cited by 59
Onozuka, I., Kakinuma, S., Kamiya, A., Miyoshi, M., Sakamoto, N., Kiyohashi, K., Watanabe, T., Funaoka, Y., Ueyama, M., Nakagawa, M., et al. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.02.012 · Cited by 58
Increased Serum Oxidative Stress Markers in Women with Uterine Leiomyoma
Santulli, P., Borghese, B., Lemaréchal, H., Leconte, M., Millischer, A., Batteux, F., Chapron, C., & Borderie, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072069 · Cited by 58
Nishizuka, I., Ichikawa, Y., Ishikawa, T., Kamiyama, M., Hasegawa, S., Momiyama, N., Miyazaki, K., & Shimada, H. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00634-6 · Cited by 57
Chegini, N., Tang, X., & Ma, C. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6147 · Cited by 56
Adipocytes Enhance the Proliferation of Human Leiomyoma Cells Via TNF-α Proinflammatory Cytokine
Nair, S., & Al-Hendy, A. A. (2011) · Reproductive Sciences · doi:10.1177/1933719111408111 · Cited by 54
Esteve, J. L. C., Acosta, R., Pérez, Y., Campos, R. V., Hernández, A. V., & Texidó, C. S. (2012) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2011.12.018 · Cited by 52
Fletcher, N. M., Saed, M. G., Abu‐Soud, H. M., Al-Hendy, A. A., Diamond, M. P., & Saed, G. M. (2013) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-013-0029-7 · Cited by 52
Growth factors and pathogenesis
Islam, M. S., Greco, S., Janjusevic, M., Ciavattini, A., Giannubilo, S. R., D'Adderio, A., Biagini, A., Fiorini, R., Castellucci, M., & Ciarmela, P. (2015) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2015.08.018 · Cited by 52
Self-citationJayes, F. L., Liu, B., Moutos, F. T., Kuchibhatla, M. N., Guilak, F., & Leppert, P. C. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.05.006 · Cited by 52
Salama, S. A., Nasr, A. B., Dubey, R. K., & Al-Hendy, A. A. (2006) · Journal of the Society for Gynecologic Investigation · doi:10.1016/j.jsgi.2006.09.003 · Cited by 51
Integrin β1 regulates leiomyoma cytoskeletal integrity and growth
Malik, M., Segars, J. H., & Catherino, W. H. (2012) · Matrix Biology · doi:10.1016/j.matbio.2012.09.005 · Cited by 51
Marsh, E. E., Steinberg, M. L., Parker, J. B., Wu, J., Chakravarti, D., & Bulun, S. E. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.05.001 · Cited by 51
Ciarmela, P., Bloise, E., Gray, P. C., Carrarelli, P., Islam, M. S., Pascalis, F. D., Severi, F. M., Vale, W., Castellucci, M., & Petraglia, F. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0501 · Cited by 50
Self-citationActivin: a novel player in tissue repair processes.
Hübner, G., Alzheimer, C., & Werner, S. (1999) · PubMed · doi:10.14670/hh-14.295 · Cited by 48
Proteoglycans of uterine fibroids and keloid scars: similarity in their proteoglycan composition
Carrino, D. A., Mesiano, S. A., Barker, N. M., Hurd, W. W., & Caplan, A. I. (2012) · Biochemical Journal · doi:10.1042/bj20111996 · Cited by 46
Hassan, M. H., Eyzaguirre, E. J., Arafa, H. M. M., Hamada, F. M. A., Salama, S. A., & Al-Hendy, A. A. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.02.010 · Cited by 46
Eichenlaub-Ritter, U., Winterscheidt, U., Vogt, E.-J., Shen, Y., Tinneberg, H., & Sorensen, R. A. (2007) · Biology of Reproduction · doi:10.1095/biolreprod.106.055111 · Cited by 46
Bützow, R. C., Fukushima, D., Twardzik, D. R., & Ruoslahti, E. I. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.122.3.721 · Cited by 44
Control of vascular endothelial growth factor angiogenic activity by the extracellular matrix
Ortéga, N., L'Faqihi, F., & Plouët, J. (1998) · Biology of the Cell · doi:10.1111/j.1768-322x.1998.tb01047.x · Cited by 42
Boulday, G., Fitau, J., Coupel, S., Soulillou, J., & Charreau, B. L. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1329.004 · Cited by 41
Ray, P. F., Vekemans, M. J. J., & Münnich, A. (2001) · Molecular Human Reproduction · doi:10.1093/molehr/7.5.489 · Cited by 40
Britten, J., Malik, M., Levy, G. A., Mendoza, M., & Catherino, W. H. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.07.1123 · Cited by 40
Plewka, A., Madej, P., Plewka, D., Kowalczyk, A. E., Miśkiewicz, A., Wittek, P., Leks, T., & Bilski, R. (2013) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.2013.0011 · Cited by 40
Study of Sperm Vitality with the Aid of Eosin-Nigrosin Stain
Williams, W. W., & POLLAK, O. J. (1950) · Fertility and Sterility · doi:10.1016/s0015-0282(16)30126-1 · Cited by 39
Suo, G., Jiang, Y. D., Cowan, B. D., & Wang, J. Y. J. (2009) · Biology of Reproduction · doi:10.1095/biolreprod.109.076869 · Cited by 38
Grudzien, M. M., Low, P. S., Manning, P. C., Arredondo, M. A., Belton, R. J., & Nowak, R. A. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.11.018 · Cited by 38
Ulipristal Acetate Modulates the Expression and Functions of Activin A in Leiomyoma Cells
Ciarmela, P., Carrarelli, P., Islam, M. S., Janjusevic, M., Zupi, E., Tosti, C., Castellucci, M., & Petraglia, F. (2014) · Reproductive Sciences · doi:10.1177/1933719114542019 · Cited by 37
Self-citationA-kinase anchoring protein-Lbc promotes pro-fibrotic signaling in cardiac fibroblasts
Cavin, S., Maric, D., & Diviani, D. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.11.008 · Cited by 36
Brauer, R., Beck, I. M., Roderfeld, M., Roeb, E., & Sedlacek, R. (2011) · BMC Biochemistry · doi:10.1186/1471-2091-12-38 · Cited by 36
Overexpression of Integrin-β1 in Leiomyoma Promotes Cell Spreading and Proliferation
Chen, H.-M., Lin, Y.-H., Cheng, Y.-M., Wing, L.-Y. C., & Tsai, S. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3647 · Cited by 36
Pharmacokinetic evaluation of ulipristal acetate for uterine leiomyoma treatment
Melis, G. B., Piras, B., Marotto, M. F., Orrù, M., Maricosu, G., Pilloni, M., Guerriero, S., Angiolucci, M., Lello, S., & Paoletti, A. M. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.695775 · Cited by 35
Increased Expression of Stromelysin 3 mRNA in Leiomyomas (Uterine Fibroids) Compared With Myometrium
PALMER, S., Haynes‐Johnson, D., Diehl, T. S., & Nowak, R. A. (1998) · Journal of the Society for Gynecologic Investigation · doi:10.1016/s1071-5576(98)00009-4 · Cited by 33
Hepatoprotective Effect of MMP-19 Deficiency in a Mouse Model of Chronic Liver Fibrosis
Jiroušková, M., Zbodakova, O., Gregor, M., Chalupský, K., Sarnová, L., Hajdůch, M., Ehrmann, J., Jirkovská, M., & Sedláček, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046271 · Cited by 33
Wolańska, M., & Bańkowski, E. (2005) · Biochimie · doi:10.1016/j.biochi.2005.07.014 · Cited by 32
Malik, M., Britten, J., Segars, J. H., & Catherino, W. H. (2014) · Reproductive Sciences · doi:10.1177/1933719114545240 · Cited by 32
Catherino, W. H., Malik, M., Driggers, P. H., Chappel, S. C., Segars, J. H., & Davis, J. B. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.05.005 · Cited by 31
Luo, X., Yin, P., Reierstad, S., Ishikawa, H., Lin, Z., Pavone, M. E., Zhao, H., Marsh, E. E., & Bulun, S. E. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1286 · Cited by 31
Malik, M., Britten, J., Cox, J. M., Patel, A. D., & Catherino, W. H. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.09.006 · Cited by 30
McCarthy-Keith, D. M., Malik, M., Britten, J., Segars, J. H., & Catherino, W. H. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.03.084 · Cited by 29
Tranilast Kissei Pharmaceutical.
Konneh, M. (1998) · PubMed · Cited by 27
Mifepristone inhibits extracellular matrix formation in uterine leiomyoma
Patel, A. D., Malik, M., Britten, J., Cox, J. M., & Catherino, W. H. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.12.021 · Cited by 27
Barker, N. M., Carrino, D. A., Caplan, A. I., Hurd, W. W., LIU, J. H., Tan, H., & Mesiano, S. A. (2015) · Reproductive Sciences · doi:10.1177/1933719115607994 · Cited by 26
Mifepristone versus placebo to treat uterine myoma: a double-blind, randomized clinical trial
Esteve, J. L. C., Tomasi, V., Acosta, Pérez, & Sanchez, C. (2013) · International Journal of Women s Health · doi:10.2147/ijwh.s42770 · Cited by 25
Stromal fibroblast activation and their potential association with uterine fibroids (Review)
Zheng, L., Cai, F., Ge, I., Biskup, E. M., & Cheng, Z. (2014) · Oncology Letters · doi:10.3892/ol.2014.2225 · Cited by 23
Vaginal mifepristone for the treatment of symptomatic uterine leiomyomata: an open-label study
Yerushalmi, G., Gilboa, Y., Jakobson‐Setton, A., Tadir, Y., Goldchmit, C., Katz, D., & Seidman, D. S. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.10.015 · Cited by 23
Increased type I and V collagen expression in uterine leiomyomas during the menstrual cycle
Iwahashi, M., & Muragaki, Y. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.12.028 · Cited by 23
Tsigkou, A., dos Reis, F. M., Ciarmela, P., Lee, M. H., Jiang, B., Tosti, C., Shen, F., Shi, Z., Chen, Y., & Petraglia, F. (2015) · Reproductive Sciences · doi:10.1177/1933719115592710 · Cited by 22
Self-citationGoss, P. E., Strasser, K., Marques, R. J., Clemons, M. J., Oza, A. M., Goel, R., Blackstein, M. E., Kaizer, L., Sterns, E. E., Nabholtz, J., et al. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006480504790 · Cited by 22
Levy, G. A., Malik, M., Britten, J., Gilden, M., Segars, J. H., & Catherino, W. H. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.03.042 · Cited by 22
Leiomyoma fibrosis inhibited by liarozole, a retinoic acid metabolic blocking agent
Gilden, M., Malik, M., Britten, J., Delgado, T., Levy, G. A., & Catherino, W. H. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.07.1132 · Cited by 21
Targeting extracellular matrix remodeling in disease: Could resveratrol be a potential candidate?
Agarwal, R., & Agarwal, P. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216675065 · Cited by 21
Chung, Y., Chae, B., Kwak, S., Song, J., Lee, A.-W., Jo, H.-H., Lew, Y.-O., Kim, J.-H., & Kim, M.-R. (2014) · International Journal of Medical Sciences · doi:10.7150/ijms.7627 · Cited by 17
High expression of cyclooxygenase-2 in uterine fibroids and its correlation with cell proliferation
Ke, X., Dou, F., Cheng, Z., Dai, H., Zhang, W., Qu, X., Peifang, D., & Zuo, X. (2013) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2013.01.006 · Cited by 17
Wu, C., Shieh, T., Wei, L., Cheng, T.-F., Chen, H.-Y., Huang, T., Wang, K.-L., & Hsia, S. (2016) · Journal of Functional Foods · doi:10.1016/j.jff.2016.02.038 · Cited by 15
Underutilization of primary medical care among men presenting for fertility evaluation
Halpern, J. A., Darves-Bornoz, A. L., Fantus, R. J., Keeter, M. K., Wren, J. M., Bennett, N., & Brannigan, R. E. (2020) · F&S Reports · doi:10.1016/j.xfre.2020.04.001 · Cited by 12
Chwalisż, K., Larsen, L. M., Mattia‐Goldberg, C., Edmonds, A., Elger, W. A. G., & Winkel, C. A. (2007) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000282008.71463.a2 · Cited by 10
Understanding Uterine Fibroids
Leppert, P. C., Fouany, M. R., & Segars, J. H. (2013) · doi:10.1002/9781118456996.ch1 · Cited by 9
Wortham, N. C., Alam, N. A., Barclay, E., Pollard, P. J., Wagner, B. E., Manek, S., Elia, G., & Tomlinson, I. P. M. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.02.106 · Cited by 9
Marsh, E. E., Chibber, S., Ju, W., Siegersma, K., Kim, J. J., & Bulun, S. E. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.12.004 · Cited by 8
Cited by
Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment
Yang, Q., Ciebiera, M., Bariani, M. V., Ali, M., Elkafas, H., Boyer, T. G., & Al-Hendy, A. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab039 · Cited by 425
Selective Progesterone Receptor Modulators—Mechanisms and Therapeutic Utility
Islam, M. S., Afrin, S., Jones, S. I., & Segars, J. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa012 · Cited by 143
Self-citation
Metadata
- Authors
- Islam, M. S., Ciavattini, A., Petraglia, F., Castellucci, M., & Ciarmela, P.
- Venue
- Human Reproduction Update
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-11-23
- Volume
- 24
- Issue
- 1
- Pages
- 59-85
- ISSN
- 1355-4786 (ISSN-L)
- 1460-2369
- OpenAlex
- W2770132733
- Cited by
- 321
- References
- 263
- FWCI
- 24.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.